Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study

Acta Diabetologica

Volumn 51, Issue 5, 2014, Pages 845-851

  Hommel, E ^a   Olsen, B ^b   Battelino, T ^c   Conget, I ^d   Schutz Fuhrmann I ^e   Hoogma, R ^f   Schierloh, U ^g   Sulli, N ^h   Gough, H ⁱ   Castaneda J ^j   de Portu, S ⁱ   Bolinder, J ^k  

^a STENO DIABETES CENTER   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d HOSPITAL CLÍNIC   (Spain)

^e Hietzing Hospital   (Austria)

^f GROENE HART HOSPITAL   (Netherlands)

^g CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^h POLICLINICO UMBERTO I   (Italy)

ⁱ Medtronic International Trading Sarl ^*  (Switzerland)

^j MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Continuous glucose monitoring; Insulin pump therapy; Medical resources; Quality of life; Sensor augmented insulin pump therapy; Treatment satisfaction

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ABSENTEEISM; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CAREGIVER; CHILD; CONTINUOUS GLUCOSE MONITORING; CONTINUOUS INFUSION; COST OF ILLNESS; DIABETIC KETOACIDOSIS; GLUCOSE SENSOR; HEALTH CARE UTILIZATION; HEALTH IMPACT ASSESSMENT; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; LENGTH OF STAY; MAJOR CLINICAL STUDY; METABOLIC REGULATION; MULTICENTER STUDY (TOPIC); PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHOOL CHILD; SELF MONITORING; TELECONSULTATION; ANALYSIS; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS, TYPE 1; ECONOMICS; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; HEALTH CARE COSTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; YOUNG ADULT;

EID: 84919464732     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0598-7     Document Type: Article

References (23)

1. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986
2. Nathan DM, Cleary PA, Backlund JY et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653
3. Nathan DM, Zinman B et al Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group (2009) Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983–2005). Arch Intern Med 169:1307–1316
4. American Diabetes Association (2011) Standards of medical care in diabetes—2011. Diabete Care 34(Suppl 1):S11–S61
5. Misso ML, Egberts KJ, Page M, O’Connor D, Shaw J (2010) Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 1:CD005103
6. Bergenstal RM, Tamborlane WV, Ahmann A et al (2010) Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 363:311–320
7. Cemeroglu AP, Stone R, Kleis L, Racine MS, Postellon DC, Wood MA (2010) Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients’ and caregivers’ perception of benefit. Pediatr Diabetes 11:182–187
8. Lombardo F, Scaramuzza AE, Iafusco D (2012) Failure of glycated hemoglobin drop after continuous subcutaneous insulin infusion initiation may indicate patients who discontinue: a 4-year follow-up study in children and adolescents with type 1 diabetes. Acta Diabetol 49(Suppl 1):S99–S105
9. Klupa T, Skupien J, Cyganek K, Katra B, Sieradzki J, Malecki M (2011) The dual-wave bolus feature in type 1 diabetes adult users of insulin pumps. Acta Diabetol 48:11–14
10. Fendler W, Baranowska A, Mianowska B, Szadkowska A, Mlynarski W (2012) Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes. Acta Diabetol 49:363–370
11. Battelino T, Conget I, Olsen B et al (2012) The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 55:3155–3162
12. Conget I, Battelino T, Giménez M et al (2011) The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy. Diabetes Technol Ther 13:49–54
13. Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL (2003) The PedsQL in type 1 and type 2 diabetes: reliability and validity of the paediatric quality of life inventory generic core scales and type 1 diabetes module. Diabetes Care 26:631–637
14. Jaeschke R, Singer J, Guyatt GH (1989) Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 10:407–415
15. Bradley C (1994) The Diabetes Treatment Satisfaction Questionnaire: DTSQs. In: Bradley C (ed) Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice. Harwood Academic Publishers, Chur, pp 3–15
16. Biderman A, Noff E, Harris SB, Friedman N, Levy A (2009) Treatment satisfaction of diabetic patients: what are the contributing factors? Fam Pract 26:102–108
17. Beck RW, Lawrence JM et al Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) Quality-of-life measures in children and adults with type 1 diabetes: juvenile diabetes research foundation continuous glucose monitoring randomized trial. Diabetes Care 33:2175–2177
18. Rubin RR, Peyrot M et al (2012) STAR 3 study group. Health-related quality of life and treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial. Diabetes Technol Ther 14:143–151
19. Nørgaard K, Scaramuzza A, Bratina N et al (2012) SAP therapy in real life: patient-reported outcomes results of the INTERPRET observational study (abstract 1058). Diabetologia 55(Suppl 1):S434
20. Lynch P, Attvall S, Persson S, Barsoe C, Gerdtham U (2012) Routine use of personal continuous glucose monitoring system with insulin pump in Sweden (abstract 1052). Diabetologia 55(Suppl1):S432
21. Rubin RR, Peyrot M (2009) Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump. J Diabetes Sci Technol 3:1402–1410
22. Bradley C, Plowright R, Stewart J, Valentine J, Witthaus E (2010) The diabetes treatment satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ. Health Qual Life Outcomes 5:57
23. Joubert M, Reznik Y (2011) Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use. Diabetes Res Clin Pract 96:294–305